Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 New and old anti-thrombotic treatments for patients with atrial fibrillation.

× No keyword cloud information.

17 in total

1. Nationwide prediction of future expenditure for protease inhibitors in chronic hepatitis C.

Authors: Dario Maratea; Andrea Messori; Valeria Fadda
Journal: Dig Liver Dis Date: 2011-09-17 Impact factor: 4.088

2. Does network meta-analysis generate any new knowledge?

Authors: Andrea Messori; Valeria Fadda; Dario Maratea; Sabrina Trippoli
Journal: Thromb Haemost Date: 2012-12-13 Impact factor: 5.249

Review 3. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.

Authors: Simon Mantha; Jack Ansell
Journal: Thromb Haemost Date: 2012-06-28 Impact factor: 5.249

Review 4. Cost-effectiveness of pharmacologic and invasive therapies for stroke prophylaxis in atrial fibrillation.

Authors: Matthew D Solomon; Aditya J Ullal; Donald D Hoang; James V Freeman; Paul Heidenreich; Mintu P Turakhia
Journal: J Cardiovasc Med (Hagerstown) Date: 2012-02 Impact factor: 2.160

5. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry.

Authors: Vivek Y Reddy; David Holmes; Shephal K Doshi; Petr Neuzil; Saibal Kar
Journal: Circulation Date: 2011-01-17 Impact factor: 29.690

6. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.

Authors: David R Holmes; Saibal Kar; Matthew J Price; Brian Whisenant; Horst Sievert; Shephal K Doshi; Kenneth Huber; Vivek Y Reddy
Journal: J Am Coll Cardiol Date: 2014-07-08 Impact factor: 24.094

7. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial.

Authors: David R Holmes; Vivek Y Reddy; Zoltan G Turi; Shephal K Doshi; Horst Sievert; Maurice Buchbinder; Christopher M Mullin; Peter Sick
Journal: Lancet Date: 2009-08-15 Impact factor: 79.321

8. Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses.

Authors: Joshua Pink; Steven Lane; Munir Pirmohamed; Dyfrig A Hughes
Journal: BMJ Date: 2011-10-31

9. Cost of dabigatran for atrial fibrillation.

Authors: Brian F Gage
Journal: BMJ Date: 2011-10-31

10. Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis.

Authors: Lars Hvilsted Rasmussen; Torben Bjerregaard Larsen; Tina Graungaard; Flemming Skjøth; Gregory Y H Lip
Journal: BMJ Date: 2012-11-05

1 in total

Review 1. Percutaneous left atrial appendage closure devices: safety, efficacy, and clinical utility.

Authors: Martin J Swaans; Lisette Is Wintgens; Arash Alipour; Benno Jwm Rensing; Lucas Va Boersma
Journal: Med Devices (Auckl) Date: 2016-09-02

1 in total